Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Thompson

Showing results (521-530 of 569) with videos related to

Pageof 57
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2024
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA CalculatorAlexander H R Varey, Isabel Li, Mary-Ann El Sharouni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III TrialAngela M Hong, Gerald B Fogarty, Kari Dolven-Jacobsen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 3, 2020
Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre studyTimothy J Kenyon-Smith, Hidde M Kroon, John T Miura, et al.
Annals of Surgical Oncology|November 15, 2023
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional ImagingCaroline A Gjorup, Rachel Woodford, Isabel Li, et al.
Cancer Cell|February 13, 2019
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined TherapyTuba N Gide, Camelia Quek, Alexander M Menzies, et al.
Annals of Surgical Oncology|March 11, 2020
International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian PatientsJüri Teras, Hidde M Kroon, John T Miura, et al.
Annals of Surgical Oncology|May 2, 2022
Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II)James W Jakub, Michael Lowe, J Harrison Howard, et al.
Trials|May 5, 2021
Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trialDeonna M Ackermann, Amelia K Smit, Monika Janda, et al.
Nature Communications|February 19, 2021
Tumour gene expression signature in primary melanoma predicts long-term outcomesManik Garg, Dominique-Laurent Couturier, Jérémie Nsengimana, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2015
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanismsDouglas B Johnson, Alexander M Menzies, Lisa Zimmer, et al.
Pageof 57

Showing results (521-530 of 569) with videos related to

Sort By:
Pageof 57
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2024
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA CalculatorAlexander H R Varey, Isabel Li, Mary-Ann El Sharouni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III TrialAngela M Hong, Gerald B Fogarty, Kari Dolven-Jacobsen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 3, 2020
Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre studyTimothy J Kenyon-Smith, Hidde M Kroon, John T Miura, et al.
Annals of Surgical Oncology|November 15, 2023
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional ImagingCaroline A Gjorup, Rachel Woodford, Isabel Li, et al.
Cancer Cell|February 13, 2019
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined TherapyTuba N Gide, Camelia Quek, Alexander M Menzies, et al.
Annals of Surgical Oncology|March 11, 2020
International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian PatientsJüri Teras, Hidde M Kroon, John T Miura, et al.
Annals of Surgical Oncology|May 2, 2022
Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II)James W Jakub, Michael Lowe, J Harrison Howard, et al.
Trials|May 5, 2021
Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trialDeonna M Ackermann, Amelia K Smit, Monika Janda, et al.
Nature Communications|February 19, 2021
Tumour gene expression signature in primary melanoma predicts long-term outcomesManik Garg, Dominique-Laurent Couturier, Jérémie Nsengimana, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2015
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanismsDouglas B Johnson, Alexander M Menzies, Lisa Zimmer, et al.
Pageof 57